- Trials with a EudraCT protocol (160)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (528)
160 result(s) found for: Ibuprofen.
Displaying page 1 of 8.
EudraCT Number: 2016-002119-16 | Sponsor Protocol Number: NORM2016-IQ | Start Date*: 2016-11-10 | |||||||||||
Sponsor Name:Aflofarm Farmacja Polska Sp. z o.o. | |||||||||||||
Full Title: Multi-center phase 3 clinical study of fever reduction effectiveness in children age 24-72 months using combined therapy (ibuprofen plus paracetamol) compared to monotherapy with paracetamol and/or... | |||||||||||||
Medical condition: Fever due to viral infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006846-24 | Sponsor Protocol Number: HTA074801 | Start Date*: 2009-02-27 |
Sponsor Name:North West London Hospitals NHS Trust | ||
Full Title: An Evaluation of the Effectiveness of Ibuprofen and Morphine for Acute Pain in Sickle Cell Disease | ||
Medical condition: Sickle Cell Disease | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002446-31 | Sponsor Protocol Number: FMLD-HUNGRIA-28_FIII | Start Date*: 2017-03-08 |
Sponsor Name:LABORATORIOS FARMALIDER S.A. | ||
Full Title: Phase III clinical trial , multicenter , randomized , double-blind , crossover, active-controlled and placebo to evaluate the analgesic efficacy and safety of paracetamol / ibuprofen 500/200 mg com... | ||
Medical condition: MODERATE TO SEVERE PAIN FOLLOWING DYSMENORRHOEA | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000736-25 | Sponsor Protocol Number: IB3M.2019 | Start Date*: 2019-09-05 |
Sponsor Name:Universidad Complutense de Madrid | ||
Full Title: Efficacy of Non-Steroidal Anti-Inflammatory (Ibuprofen) Chronotherapy in Healing After Mandibular Third Molar Surgical Extraction – A Randomized Clinical Trial | ||
Medical condition: The clinical trial will try to understand if the elimination of the ibuprofen dosage in resting phase after surgical third molar extraction not jeopardize the postoperative period . | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006762-29 | Sponsor Protocol Number: NL0804 | Start Date*: 2009-01-16 | |||||||||||
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | |||||||||||||
Full Title: A double-blind, randomised, crossover, single dose, single centre, study examining the analgesic efficacy and tolerability of fixed-dose combinations of ibuprofen 200mg and acetaminophen 500mg, ibu... | |||||||||||||
Medical condition: Primary Dysmenorrhoea | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000242-35 | Sponsor Protocol Number: 18CT0003 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:E-Pharma Trento SpA | |||||||||||||
Full Title: Randomized, double blind, double dummy, parallel-groups, clinical trial on efficacy and safety of ibuprofen/N-acetylcysteine fixed dose combination vs. individual components (ibuprofen and N-acetyl... | |||||||||||||
Medical condition: symptomatic non-complicated upper respiratory tract infections | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001442-34 | Sponsor Protocol Number: IBUPAI0002 | Start Date*: 2013-08-06 |
Sponsor Name:McNeil AB | ||
Full Title: A SINGLE-DOSE, RANDOMIZED, TWO-PERIOD, CROSSOVER STUDY TO ASSESS BIOEQUIVALENCE BETWEEN TWO IBUPROFEN 200 MG TABLET FORMULATIONS, IN HEALTHY ADULTS. | ||
Medical condition: Pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002137-39 | Sponsor Protocol Number: V1 25/07/04 | Start Date*: 2004-09-17 |
Sponsor Name: | ||
Full Title: A randomised controlled trial of the combined use of paracetamol and ibuprofen to treat febrile children | ||
Medical condition: Fevers in childhood not asscoaited with severe disease in the immunocompenetent or fever in the immunocompromised host. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004267-30 | Sponsor Protocol Number: Gebro-III-21-10 | Start Date*: 2005-02-21 |
Sponsor Name:Gebro Pharma GmbH | ||
Full Title: Efficacy and Tolerability of Dexibuprofen Film coated tablets in Comparison to Ibuprofen in Children and Adolescents with Tonsillopharyngitis | ||
Medical condition: Tonsillopharyngitis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002779-32 | Sponsor Protocol Number: PREEMTIVE | Start Date*: 2019-12-26 |
Sponsor Name:BERTA CASTELLANO PAULIS | ||
Full Title: “Pre-emptive analgesia with Ibuprofen in outpatient laparoscopic cholecystectomy. Recovery Quality ” | ||
Medical condition: AMBULATORY LAPAROSCOPIC COLECISTECTOMY | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001143-32 | Sponsor Protocol Number: Algofrenelle-01 | Start Date*: 2018-07-27 | ||||||||||||||||
Sponsor Name:Ioulia and Irene Tseti Pharmaceutical Laboratories S.A., d.t. "Intermed S.A." | ||||||||||||||||||
Full Title: Efficacy of a new ibuprofen formulation for vaginal application | ||||||||||||||||||
Medical condition: Analgesic and anti-inflammatory action after gynecological surgical procedures | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: GR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005240-33 | Sponsor Protocol Number: MENTH001 | Start Date*: 2016-02-26 | |||||||||||
Sponsor Name:The Mentholatum Company Ltd | |||||||||||||
Full Title: A single centre, randomised, single-blind, parallel group single dose study to compare the speed of onset of ibuprofen gel, ibuprofen gel with levomenthol, and diclofenac gel in the relief of pain ... | |||||||||||||
Medical condition: Pain of strains, sprains and sports injuries | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002436-31 | Sponsor Protocol Number: ALGIPED | Start Date*: 2023-05-16 | |||||||||||
Sponsor Name:Dicofarm S.p.A. | |||||||||||||
Full Title: Randomized, controlled, transversal phase IV study on the efficacy and speed of action of lysin ibuprofen vs ibuprofen on the treatment of acute pain in children (ALGIPED). | |||||||||||||
Medical condition: Acute pain in pediatric age | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Not Authorised) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004077-32 | Sponsor Protocol Number: BCRU/11/Ibu-AOM/001 | Start Date*: 2015-12-29 |
Sponsor Name:Berlin-Chemie AG | ||
Full Title: A randomized open-label, multinational, multicentre, phase III clinical study to evaluate the efficacy and safety of Ibuprofen oral suspension 20 mg/ml and Ibuprofen oral suspension 40 mg/ml (Berli... | ||
Medical condition: Acute otitis media (AOM) is an acute inflammatory disease involving the mucosa of the middle ear. AOM is one of the most frequent complications of upper respiratory tract infections in children. T... | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-004176-35 | Sponsor Protocol Number: AH-09-10 | Start Date*: 2015-06-26 |
Sponsor Name:Pfizer | ||
Full Title: Evaluation Of The Efficacy Of A Novel Ibuprofen Formulation In The Treatment Of Post Surgical Dental Pain: Study I | ||
Medical condition: Post Surgical Dental Pain | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-018771-23 | Sponsor Protocol Number: 2010-0128771-23 | Start Date*: 2010-03-03 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA "S. CROCE E CARLE" | |||||||||||||
Full Title: Therapy of patency of ductus arteriosus (PDA) in very low birth weight (VLBW)preterm infants: oral ibuprofen versus intravenous ibuprofen | |||||||||||||
Medical condition: treatment on pharmacological closure of patent ductus arteriosus (PDA)in preterm very low birthweight infants. | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003177-14 | Sponsor Protocol Number: IBUPAR-Trial | Start Date*: 2016-04-06 |
Sponsor Name: | ||
Full Title: Paracetamol versus ibuprofen in preterm infants with a hemodynamically significant patent ductus arteriosus: a randomized clinical trial. | ||
Medical condition: Persistent ductus arteriosus haemodynamically significant | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002776-14 | Sponsor Protocol Number: 97 | Start Date*: 2013-03-15 | |||||||||||
Sponsor Name:University of Oslo, Faculty of medicine, Institute of Health and Society | |||||||||||||
Full Title: Ibuprofen versus mecillinam for uncomplicated cystitis in adult, non-pregnant women | |||||||||||||
Medical condition: Uncomplicated cystitis in adult, non pregnant women, age 18-60. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NO (Completed) DK (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000138-37 | Sponsor Protocol Number: FMLD-HUNGRIA-2-42_FIII | Start Date*: 2018-04-25 |
Sponsor Name:Laboratorios Farmalíder S.A. | ||
Full Title: PHASE III CLINICAL TRIAL FOR THE EVALUATION OF THE EFFICACY AND SAFETY OF A PARACETAMOL + IBUPROFEN COMBINATION IN PATIENTS WITH PRIMARY DYSMENORRHOEA | ||
Medical condition: DYSMENORRHOEA | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003790-41 | Sponsor Protocol Number: JAN12006-01 | Start Date*: 2015-05-11 |
Sponsor Name:Spherium Biomed | ||
Full Title: Randomised, double-blinded, placebo and active comparator controlled exploratory clinical trial to assess the efficacy and safety of a triple combination of Ibuprofen, magnesium and ascorbic acid ... | ||
Medical condition: Temporomandibular joint dysfunction syndrome. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
